Inmed PharmaceuticalsINM
13F holders, Q1 2026 (March 31)9holders +2
4new positions
2sold out
1famous investor
$0.65avg. 13F price*
At the end of Q1 2026, 9 institutions reported holding Inmed Pharmaceuticals Inc. (INM) in their 13F filings, up 2 from Q4 2025. 4 opened new positions and 2 sold out. The largest holders were Sabby Management, LLC ($142K), Citadel Advisors ($30K) and Virtu Financial LLC ($13K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Inmed Pharmaceuticals Inc.
- CUSIP
- 457637700
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $59K |
| Exits | 2 | $26K |
All 13F filers, Q4 2025 → Q1 2026: 116,989 shares bought and 24,731 shares sold, net +92,258 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Sabby Management, LLC | 2.69% | Add +9.2% | 220,260 | $142K |
| Citadel Advisors | 0.00% | New | 46,973 | $30K |
| Virtu Financial LLC | 0.00% | New | 19,980 | $13K |
| Two Sigma Securities, LLC | 0.00% | New | 18,718 | $12K |
| UBS Group AG | 0.00% | Add +2040.0% | 8,068 | $5K |
| Private Wealth Management Group, LLC | 0.00% | New | 5,000 | $3K |
| SBI Securities Co., Ltd. | 0.00% | No change | 300 | $193 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 2 | $2 |
| Banque Cantonale Vaudoise | 0.00% | No change | 6 | $0 |
"% of holder's portfolio" is INM's weight in each manager's 13F, not the share of Inmed Pharmaceuticals Inc. the manager owns.